Johnson & Johnson is currently seeking a Director, Q&C Acquisitions and Divestitures (PMO) located in New Brunswick, NJ with consideration given to support from other US based J&J office locations. This is a duration-based project expected to conclude on December 31st, 2027. About MedTech Fueled by innovation at the intersection of biology and technology, we’re developing the next generation of smarter, less invasive, more personalized treatments. Your unique talents will help patients on their journey to wellness. Learn more at https://www.jnj.com/medtech JOB SUMMARY Responsible for projects within MedTech (MT) Q&C Acquisitions and Divestitures (A&D), which include A&D assessment, investigation (due diligence/reverse due diligence), and Integration/Separation planning and execution. Responsible for shaping, architecting, and delivering the PMO separation strategy for Project Osprey (DPS separation). This role will ensure continuity of quality processes and regulatory compliance during separation. It will coordinate global teams to map and define dispositions for processes, documents and systems, and drive the implementation of Quality applications required for DPS to operate independently. The role is a senior program leadership position requiring cross‑functional influence, regulatory understanding, deep Quality Systems experience, and the ability to lead organizational change in a regulated environment while minimizing risk to product supply and patient safety. The leader shall work in collaboration with other functions, such as Regulatory Affairs and Supply Chain, and with other Quality Workstreams, to resolve interdependencies and ensure aligned handovers
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director